Last reviewed · How we verify

NCT03686943: RIMPAP

Iatrogenic Drug Risk in People Over 75, With or Without Cognitive Disorders, From an Inventory of Their Family Pharmacy

Withdrawn Last updated 26 September 2019
What this trial tests

trial testing Family pharmacy in Elderly. Withdrawn.

Timeline
28 June 2019
Primary endpoint
28 June 2019
28 June 2019

Quick facts

Lead sponsorUniversity Hospital, Tours
StatusWithdrawn
Study typeOBSERVATIONAL
Start date28 June 2019
Primary completion28 June 2019
Estimated completion28 June 2019

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Tours

Who can join

75 and older, any sex, with Elderly or Iatrogenic Drug Risk. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Many hospitalizations or emergency room visits are due to problems of iatrogenic medication, especially in elderly patients who are very often polymedicated. Moreover, they are more at risk because of fragility. This has an important socio-economic impact. It therefore seems important to act upstream of these adverse events and a review of the drugs available in the homes of elderly patients seems a good starting point.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Elderly

Currently open trials in the same condition.

Other University Hospital, Tours trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03686943.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing